Worksite Influenza Immunization Programs: Insight into the Implementation and Cost-Benefit

Workplace Health and Safety

Volumn 53, Issue 3, 2005, Pages 105-110

  Olsen, Geary W ^a   Steinberg, Marianne E ^a   Ley, Carol A ^a  

^a 3M COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; COST BENEFIT ANALYSIS; COST CONTROL; COST OF ILLNESS; ECONOMIC MODEL; ECONOMICS; FEASIBILITY STUDY; HUMAN; INFLUENZA, HUMAN; OCCUPATIONAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; PRIMARY PREVENTION; PROCEDURES; PRODUCTIVITY; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; TRANSMISSION; WORKPLACE;

ABSENTEEISM; COST OF ILLNESS; COST SAVINGS; COST-BENEFIT ANALYSIS; EFFICIENCY; FEASIBILITY STUDIES; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA, HUMAN; MODELS, ECONOMIC; OCCUPATIONAL HEALTH SERVICES; PRIMARY PREVENTION; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; WORKPLACE;

EID: 18244392682     PISSN: 21650799     EISSN: 21650969     Source Type: Journal    
DOI: 10.1177/216507990505300309     Document Type: Note

References (25)

1. Advisory Committee on Immunization Practices (ACIP). (2003). Prevention and control of influenza. Morbidity Mortality Weekly Report, 52(RR08), 1–36.
2. Bridges C.B., Meltzer M.I., & Thompson W.W. (2001). Influenza vaccine for healthy working adults [Letter to editor]. Journal of the American Medical Association, 285, 292.
3. Bridges C.B., Thompson W.W., Meltzer M.I., Reeve G.R., Talamonti W.J., Cox N.J., Lilac N.J., Lilac J.A., Hall H., Klimov A., & Fukuda K. (2000). Effectiveness and cost-benefit of influenza vaccination of healthy working adults. Journal of the American Medical Association, 284, 1655–1663.
4. Burckel E., Ashraf T., de Sousa Filho J.P.G., Neto E.F., Guarino H., Yauti C., de Barros Barreto F., & Champion L. (1999). Economic impact of providing workplace influenza vaccination. Pharmacoeconomics, 16, 563–576.
5. Burris J., Olsen G.W., Burlew M.M., Steinberg M.E., Stoltzfus J.A., & Mandel J.H. (1999). Workplace influenza immunization update [Letter to editor]. Journal of Occupational and Environmental Medicine, 41, 415.
6. Byrnes G.B., & Kelly H. (2001). Influenza vaccine for healthy working adults [Letter to editor]. Journal of the American Medical Association, 285, 290–291.
7. Couch R.B. (2000). Prevention and treatment of influenza. New England Journal of Medicine, 343, 1778–1787.
8. Cox J.N., & Subbarao K. (1999). Influenza. Lancet, 354, 1277–1282.
9. Decisoneering. (2004). What is Monte Carlo simulation? Retrieved January 29, 2005 from, http://www.decisioneering.com/monte-carlo-simulation.html
10. Food and Drug Administration (FDA). (2004). Quick summary: Vaccines and Related Biological Products Advisory Committee. Retrieved August 9, 2004, from http://www.fda.gov/ohrms/dock-ets/ac/04/minutes/4020ml_quick%20summary.htm
11. Levy E. (1996). French economic evaluations of influenza and influenza vaccination. Pharmacoeconomics, 9(Suppl. 3), 62–66.
12. Nichol K.L. (2001a). Cost–benefit analysis of a strategy to vaccinate healthy working adults against influenza. Archives Internal Medicine, 161, 749–759.
13. Nichol K.L. (2001b). Influenza vaccine for healthy working adults [Letter to editor]. Journal of the American Medical Association, 285, 290.
14. Nichol K.L., Lind A., Margolis K.L., Murdoch M., McFadden R., Hague M., Magnan S., & Drake M. (1995). The effectiveness of vaccination against influenza in healthy, working adults. New England Journal of Medicine, 333, 889–893.
15. Nichol K.L., Mallon K.P., & Mendelman P.M. (2003). Cost benefit of influenza vaccination in healthy, working adults: An economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine, 21, 2207–2217.
16. Nichol K.L., Mendelman P.M., Mallon K.P., Jackson L.A., Gorse G.J., Belshe R.B., Glezen W.P., & Wittes J. (1999). Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults. Journal of the American Medical Association, 281, 137–144.
17. Olsen G.W., Burris J.M., Burlew M.M., Steinberg M.E., Patz N.V., Stoltzfus J.A., & Mandel J.H. (1998). Absenteeism among employees who participated in a workplace influenza immunization program. The Journal of Occupational and Environmental Medicine, 40, 311–316.
18. Postma M.J., Jansema P., van Genugten M.L.L., Heijnen M.L.A., Jager J.C., & de Jong-van den Berg L.T.W. (2002). Pharmacoeconomics of influenza vaccination for healthy working adults. Drugs, 62, 1013–1024.
19. Principi N., Esposito S., Marchisio P., Gasparini R., & Crovari P. (2003). Socioeconomic impact of influenza on healthy children and their families. Pediatric Infectious Disease Journal, 22, S207–210.
20. Saxen H., & Virtanen M. (1999). Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers. Pediatric Infectious Disease Journal, 18, 779–783.
21. Terebuh P., Uyeki T., & Fukuda K. (2003). Impact of influenza on young children and the shaping of United States influenza vaccine policy. Pediatric Infectious Disease Journal, 22, S231–235.
22. Treanor J.J., Kotloff K., Betts R.F., Belshe R., Newman F., Iacuzio D., Wittes J., & Bryant M. (2000). Evaluation of trivalent, live, cold-adapted (LAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine, 18, 899–906.
23. Weingarten S., Staniloff H., Ault M., Miles P., Bamberger M., & Meyer R.D. (1988). Do hospital employees benefit from the influenza vaccine? Journal of General Internal Medicine, 3(1), 32–37.
24. Wilde J.A., McMillan J.A., Serwint J., Butta J., O'Riordan M.A., & Steinhoff M.C. (1999). Effectiveness of influenza vaccine in health care professionals. Journal of the American Medical Association, 281, 908–913.
25. Wood S.C., Van Hung N., & Schmidt S. (2000). Economic evaluations of influenza vaccination in healthy working-age adults. Pharmacoeconomics, 18, 173–183.